PAO Group, Inc.: PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market
ALKM - Alkame Confirms $15 Million Annual Revenue Bottling Production Potential
PAOG recenlty released a preview of the company s plan to launch a CBD Nutraceuticals line of products. PAOG s CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.
PAOG plans to develop and distribute its CBD nutraceuticals ALKM as a copacker, and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) as a distributor.
The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.